StockData

Aibotics, Inc. (AIBT) stock

AIBTOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 0/30
$0.00+0.00 (+42.86%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Aibotics net income

Net income is the profit left for shareholders after every expense, interest and tax.

Aibotics's net income for the twelve months ending Jun 30, 2026 was -$2.09M. For fiscal 2025 it was -$2.22M. The highest annual figure on record is -$16.03K in fiscal 2020.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.22M–
FY2024Dec 31, 2024-$1.85M–
FY2023Dec 31, 2023-$1.18M–
FY2022Dec 31, 2022-$2.61M–
FY2021Dec 31, 2021-$5.14M–
FY2020Dec 31, 2020-$16.03K–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$536.97K–
Q1 FY2026Mar 31, 2026-$418.11K–
Q4 FY2025Dec 31, 2025-$608.28K–
Q3 FY2025Sep 30, 2025-$529.92K–
Q2 FY2025Jun 30, 2025-$486.15K–
Q1 FY2025Mar 31, 2025-$591.40K–
Q4 FY2024Dec 31, 2024-$491.51K–
Q3 FY2024Sep 30, 2024-$460.14K–
Q2 FY2024Jun 30, 2024-$470.68K–
Q1 FY2024Mar 31, 2024-$425.94K–
Q4 FY2023Dec 31, 2023-$290.96K–
Q3 FY2023Sep 30, 2023-$308.70K–
Q2 FY2023Jun 30, 2023-$278.68K–
Q1 FY2023Mar 31, 2023-$303.00K–
Q4 FY2022Dec 31, 2022-$603.59K–
Q3 FY2022Sep 30, 2022-$292.63K–
Q2 FY2022Jun 30, 2022-$410.94K–
Q1 FY2022Mar 31, 2022-$1.30M–
Q4 FY2021Dec 31, 2021-$2.64M–
Q3 FY2021Sep 30, 2021-$2.39M–
Q2 FY2021Jun 30, 2021-$107.41K–
Q1 FY2021Mar 31, 2021-$8.24K–
Q4 FY2020Dec 31, 2020-$7.74K–
Q3 FY2020Sep 30, 2020-$6.48K–
Q2 FY2020Jun 30, 2020-$1.65K–
Q1 FY2020Mar 31, 2020-$157–

More Aibotics figures

See a number that looks wrong?